Search

everythinglearnresearchcommunity

for

Search:↓

Cellcurin therapy with microneedling increases hair density and thickness in treating hair loss in men and women.

There's a significant link between severe hair loss and metabolic syndrome in Saudi Arabia, suggesting early health checks could prevent future issues.

Some breast cancer chemotherapy can cause permanent hair loss.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Hair loss severity is linked to depression, not anxiety, in Filipino men, with older, less educated men with more hair loss at higher risk.

DHT, a testosterone byproduct, causes male pattern baldness.

Topical finasteride with minoxidil is effective for treating hair loss and may reduce the need for oral finasteride.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Minoxidil and photobiomodulation together improve hair growth better than minoxidil alone.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Low-level laser therapy is safe but not significantly better than minoxidil alone for hair growth.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Kids with skin problems are more likely to have mental health issues.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Male Androgenetic Alopecia, a common hair loss in men, can be slowed and partially restored with treatments like minoxidil and finasteride, or hair transplantation. Serenoa repens may be an alternative treatment. More research is needed for new treatments.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.